Tag
Numinus Wellness Inc.
- Numinus partners with HealingMaps to promote its clinics and identify expansion targets
- Numinus Wellness launches new psychedelics clinic licensing model for independent practitioners
- Numinus develops psilocybin-infused tea bag for clinical studies
- Numinus launches ketamine-assisted therapy in Toronto
- DOSED 2 screening sells out at Vancouver's Rio Theatre
- Psychedelic use rising as the market expands: MicroSmallCap
- Numinus to offer ketamine-assisted psychotherapy
- Numinus announces Music as Medicine event series
- Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year
- Numinus to enter US psychedelics market via $26.2M Novamind acquisition
- Numinus gets new biosecurity licence to expand psilocybin research
- Canadian health professionals are limited to clinical trials to access psilocybin. Experts say that's unethical
- Numinus uplists to OTCQX Best Market
- Numinus ups revenue 61% thanks to psychedelic-focused therapy programs
- Numinus submits novel psilocybe formulation for clinical trial
- What amendments to Canada's restricted drug program mean for patients and practitioners
- Health Canada to increase legal access to psychedelics for therapy
- Numinus to start trading on TSX
- Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M
- Numinus to test natural psilocybin safety in Phase 1 trial
- MagicMed aims to mainstream psychedelic therapy with world's largest 'Psybrary'
- Canada could regulate psychedelic therapy within few years, bets company